<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'>
<collection>
  <source>SourceData</source>
  <date>00000000</date>
  <key>sourcedata.key</key>
  <document>
    <id>4772951 Figure_1-A</id>
    <infon key="sourcedata_document">1413</infon>
    <infon key="doi">10.15252/emmm.201505495</infon>
    <infon key="pmc_id">4772951</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>GSC neurospheres were dissociated to single cell suspension and transfected with either miR-10b inhibitor (labeled "miR-10b-i") or non-targeting control oligonucleotide, or treated with Lipofectamine 2000 only (Mock). Statistical significance of the difference was determined by Student's t test, with p-values &lt; 0.001 indicated by three asterisks. Numbers of replicates and exact P-values are included in Appendix Table S4. A. Cell viability was monitored at day 5 after transfection as described in Materials and Methods.</text>
      <annotation id="1">
        <infon key="type">CL:0000047</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">1</infon>
        <location offset="0" length="3"/>
        <text>GSC</text>
      </annotation>
      <annotation id="2">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">2</infon>
        <location offset="88" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="3">
        <infon key="type">CHEBI:7754</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">3</infon>
        <location offset="153" length="15"/>
        <text>oligonucleotide</text>
      </annotation>
      <annotation id="4">
        <infon key="type">molecule:Lipofectamine 2000</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">4</infon>
        <location offset="186" length="18"/>
        <text>Lipofectamine 2000</text>
      </annotation>
      <annotation id="5">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">5</infon>
        <location offset="116" length="7"/>
        <text>miR-10b</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772951 Figure_1-B</id>
    <infon key="sourcedata_document">1413</infon>
    <infon key="doi">10.15252/emmm.201505495</infon>
    <infon key="pmc_id">4772951</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. The number and size of GSC colonies were monitored at day 5 after transfection.</text>
      <annotation id="1">
        <infon key="type">CL:0000047</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">11</infon>
        <location offset="26" length="3"/>
        <text>GSC</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772951 Figure_1-C</id>
    <infon key="sourcedata_document">1413</infon>
    <infon key="doi">10.15252/emmm.201505495</infon>
    <infon key="pmc_id">4772951</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. MiR-10b inhibition induces cleavage of caspases 3 and 7 in GSC, as determined by Western blot analysis at day 5 after transfection with the inhibitor. The signals were quantified using ImageJ and normalized to beta-actin.</text>
      <annotation id="1">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">20</infon>
        <location offset="3" length="7"/>
        <text>MiR-10b</text>
      </annotation>
      <annotation id="2">
        <infon key="type">Uniprot:P42574</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">21</infon>
        <location offset="42" length="10"/>
        <text>caspases 3</text>
      </annotation>
      <annotation id="3">
        <infon key="type">CL:0000047</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">22</infon>
        <location offset="62" length="3"/>
        <text>GSC</text>
      </annotation>
      <annotation id="4">
        <infon key="type">protein:beta-actin</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">25</infon>
        <location offset="213" length="10"/>
        <text>beta-actin</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772951 Figure_1-D</id>
    <infon key="sourcedata_document">1413</infon>
    <infon key="doi">10.15252/emmm.201505495</infon>
    <infon key="pmc_id">4772951</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. Flow Cytometry analysis of Annexin V and 7-AAD staining of GSCGBM8 at day 5 after miR-10b inhibition.</text>
      <annotation id="1">
        <infon key="type">CL:0000047</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">32</infon>
        <location offset="62" length="3"/>
        <text>GSC</text>
      </annotation>
      <annotation id="2">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">34</infon>
        <location offset="85" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="3">
        <infon key="type">CL:0000047</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">35</infon>
        <location offset="65" length="4"/>
        <text>GBM8</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772951 Figure_2-A</id>
    <infon key="sourcedata_document">1413</infon>
    <infon key="doi">10.15252/emmm.201505495</infon>
    <infon key="pmc_id">4772951</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>Three types of GSC (GBM4, GBM6, and GBM8) were transfected with miR-10bASO, and gene expression was analyzed 24 hours later by the Affymetrix microarrays. The heatmaps colors intensity demonstrate altered expression of the genes (up- or down-regulated relative to the mock treated samples) with the fold change &gt; 1.2 and p &lt; 0.05 in at least two out of the three GSC cultures. A. The genes associated with "cell cycle" bioterm have been selected using Ingenuity Pathway Analysis. The treatment with the miR-10b inhibitor is indicated as "miR-10b-i".</text>
      <annotation id="1">
        <infon key="type">CHEBI:76720</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">36</infon>
        <location offset="71" length="3"/>
        <text>ASO</text>
      </annotation>
      <annotation id="2">
        <infon key="type">CL:0000047</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">39</infon>
        <location offset="15" length="3"/>
        <text>GSC</text>
      </annotation>
      <annotation id="3">
        <infon key="type">CL:0000047</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">40</infon>
        <location offset="20" length="4"/>
        <text>GBM4</text>
      </annotation>
      <annotation id="4">
        <infon key="type">CL:0000047</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">41</infon>
        <location offset="26" length="4"/>
        <text>GBM6</text>
      </annotation>
      <annotation id="5">
        <infon key="type">CL:0000047</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">42</infon>
        <location offset="36" length="4"/>
        <text>GBM8</text>
      </annotation>
      <annotation id="6">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">43</infon>
        <location offset="64" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="7">
        <infon key="type">CL:0000047</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">44</infon>
        <location offset="363" length="3"/>
        <text>GSC</text>
      </annotation>
      <annotation id="8">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">45</infon>
        <location offset="503" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="9">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">46</infon>
        <location offset="538" length="7"/>
        <text>miR-10b</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772951 Figure_2-B</id>
    <infon key="sourcedata_document">1413</infon>
    <infon key="doi">10.15252/emmm.201505495</infon>
    <infon key="pmc_id">4772951</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. The genes associated with "RNA splicing" bioterm have been selected using Gene Ontology (GO). The treatment with the miR-10b inhibitor is indicated as "miR-10b-i". Arrows depict the genes selected as candidate direct targets for further study.</text>
      <annotation id="1">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">47</infon>
        <location offset="120" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="2">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">48</infon>
        <location offset="155" length="7"/>
        <text>miR-10b</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772951 Figure_2-C</id>
    <infon key="sourcedata_document">1413</infon>
    <infon key="doi">10.15252/emmm.201505495</infon>
    <infon key="pmc_id">4772951</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. miR-10b binding motifs are enriched in 5'UTRs of the genes up-regulated by miR-10bASO. The graph shows the probability that enrichment of the miR-10b motifs in mRNAs up-regulated vs. unchanged (p&lt;0.05) by anti-miR-10b does not occur by chance.</text>
      <annotation id="1">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">56</infon>
        <location offset="3" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="2">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">57</infon>
        <location offset="78" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="3">
        <infon key="type">CHEBI:76720</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">58</infon>
        <location offset="85" length="3"/>
        <text>ASO</text>
      </annotation>
      <annotation id="4">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">59</infon>
        <location offset="213" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="5">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">60</infon>
        <location offset="145" length="7"/>
        <text>miR-10b</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772951 Figure_2-D</id>
    <infon key="sourcedata_document">1413</infon>
    <infon key="doi">10.15252/emmm.201505495</infon>
    <infon key="pmc_id">4772951</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. The miR-10b octamer motifs' composition of the 5'UTRs was compared between transcripts up- and down-regulated on the microarrays. The relative frequencies of various miR-10b binding motifs are shown, indicating that mostly miR-10b 3'-end binding motifs are enriched in the up-regulated mRNAs.</text>
      <annotation id="1">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">63</infon>
        <location offset="7" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="2">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">64</infon>
        <location offset="169" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="3">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">65</infon>
        <location offset="226" length="7"/>
        <text>miR-10b</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772951 Figure_3-A</id>
    <infon key="sourcedata_document">1413</infon>
    <infon key="doi">10.15252/emmm.201505495</infon>
    <infon key="pmc_id">4772951</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>Figure 3. Expression analysis of splicing factor mRNAs in various GBM datasets. A. The genes encoding splicing factors down-regulated by miR-10b are expressed at lower levels in various GBM datasets relative to their expression in normal brain tissues. B. In contrast, many splicing factors up-regulated by miR-10b are overexpressed in the GBM datasets. Six high-content GBMmicroarray datasets from the Oncomine resource (https://www.oncomine.org/resource/main.html), including TCGA_BrainGBM (2), Bredel Brain2 (31), Lee Brain (32), Liang Brain (33), Murat Brain (34) and Sun Brain (35), that collectively contain information for 858 GBM and 52 control samples, have been utilized for the analysis. The data is presented as log2 fold change between GBM and normal brain tissues.</text>
      <annotation id="1">
        <infon key="type">CL:0000047</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">66</infon>
        <location offset="186" length="3"/>
        <text>GBM</text>
      </annotation>
      <annotation id="2">
        <infon key="type">CL:0000047</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">67</infon>
        <location offset="66" length="3"/>
        <text>GBM</text>
      </annotation>
      <annotation id="3">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">68</infon>
        <location offset="137" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="4">
        <infon key="type">Uberon:UBERON:0000955</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">69</infon>
        <location offset="238" length="5"/>
        <text>brain</text>
      </annotation>
      <annotation id="5">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">70</infon>
        <location offset="307" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="6">
        <infon key="type">CL:0000047</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">71</infon>
        <location offset="340" length="3"/>
        <text>GBM</text>
      </annotation>
      <annotation id="7">
        <infon key="type">CL:0000047</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">72</infon>
        <location offset="371" length="3"/>
        <text>GBM</text>
      </annotation>
      <annotation id="8">
        <infon key="type">Uberon:UBERON:0000955</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">74</infon>
        <location offset="521" length="5"/>
        <text>Brain</text>
      </annotation>
      <annotation id="9">
        <infon key="type">Uberon:UBERON:0000955</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">75</infon>
        <location offset="539" length="5"/>
        <text>Brain</text>
      </annotation>
      <annotation id="10">
        <infon key="type">Uberon:UBERON:0000955</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">76</infon>
        <location offset="557" length="5"/>
        <text>Brain</text>
      </annotation>
      <annotation id="11">
        <infon key="type">Uberon:UBERON:0000955</infon>
        <infon key="sourcedata_figure_annot_id">11</infon>
        <infon key="sourcedata_article_annot_id">77</infon>
        <location offset="576" length="5"/>
        <text>Brain</text>
      </annotation>
      <annotation id="12">
        <infon key="type">CL:0000047</infon>
        <infon key="sourcedata_figure_annot_id">12</infon>
        <infon key="sourcedata_article_annot_id">78</infon>
        <location offset="634" length="3"/>
        <text>GBM</text>
      </annotation>
      <annotation id="13">
        <infon key="type">CL:0000047</infon>
        <infon key="sourcedata_figure_annot_id">13</infon>
        <infon key="sourcedata_article_annot_id">79</infon>
        <location offset="749" length="3"/>
        <text>GBM</text>
      </annotation>
      <annotation id="14">
        <infon key="type">Uberon:UBERON:0000955</infon>
        <infon key="sourcedata_figure_annot_id">14</infon>
        <infon key="sourcedata_article_annot_id">80</infon>
        <location offset="764" length="5"/>
        <text>brain</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772951 Figure_4-B</id>
    <infon key="sourcedata_document">1413</infon>
    <infon key="doi">10.15252/emmm.201505495</infon>
    <infon key="pmc_id">4772951</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. qRT-PCR analysis validates that mRNA of MBNL1-3, SART3, RSRC1 and other splicing factors are de-repressed by miR-10bASO in different GSC and GBMcell lines. mRNA expression levels were normalized to GAPDH expression.</text>
      <annotation id="1">
        <infon key="type">NCBI gene:4154</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">82</infon>
        <location offset="43" length="5"/>
        <text>MBNL1</text>
      </annotation>
      <annotation id="2">
        <infon key="type">NCBI gene:9733</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">83</infon>
        <location offset="52" length="5"/>
        <text>SART3</text>
      </annotation>
      <annotation id="3">
        <infon key="type">NCBI gene:51319</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">84</infon>
        <location offset="59" length="5"/>
        <text>RSRC1</text>
      </annotation>
      <annotation id="4">
        <infon key="type">gene:GAPDH</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">85</infon>
        <location offset="201" length="5"/>
        <text>GAPDH</text>
      </annotation>
      <annotation id="5">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">87</infon>
        <location offset="112" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="6">
        <infon key="type">CHEBI:76720</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">88</infon>
        <location offset="119" length="3"/>
        <text>ASO</text>
      </annotation>
      <annotation id="7">
        <infon key="type">CL:0000047</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">89</infon>
        <location offset="136" length="3"/>
        <text>GSC</text>
      </annotation>
      <annotation id="8">
        <infon key="type">CL:0000047</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">90</infon>
        <location offset="144" length="3"/>
        <text>GBM</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772951 Figure_4-C</id>
    <infon key="sourcedata_document">1413</infon>
    <infon key="doi">10.15252/emmm.201505495</infon>
    <infon key="pmc_id">4772951</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. Regulation of representative splicing-related proteins by miR-10b mimic in GSC, as demonstrated by Western blot analysis. The signals were quantified using ImageJ and normalized to beta-actin. The ratios between miR-10b mimic expressing and control samples are indicated.</text>
      <annotation id="1">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">102</infon>
        <location offset="61" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="2">
        <infon key="type">CL:0000047</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">103</infon>
        <location offset="78" length="3"/>
        <text>GSC</text>
      </annotation>
      <annotation id="3">
        <infon key="type">protein:beta-actin</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">105</infon>
        <location offset="184" length="10"/>
        <text>beta-actin</text>
      </annotation>
      <annotation id="4">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">106</infon>
        <location offset="215" length="7"/>
        <text>miR-10b</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772951 Figure_4-D</id>
    <infon key="sourcedata_document">1413</infon>
    <infon key="doi">10.15252/emmm.201505495</infon>
    <infon key="pmc_id">4772951</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. miR-10b mimic regulates 5'UTR Luciferase reporter containing a single miR-10b complementary site.</text>
      <annotation id="1">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">115</infon>
        <location offset="73" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="2">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">116</infon>
        <location offset="3" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="3">
        <infon key="type">gene:Luciferase</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">411</infon>
        <location offset="33" length="10"/>
        <text>Luciferase</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772951 Figure_4-E</id>
    <infon key="sourcedata_document">1413</infon>
    <infon key="doi">10.15252/emmm.201505495</infon>
    <infon key="pmc_id">4772951</infon>
    <infon key="figure">Figure 4-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E</infon>
    <passage>
      <offset>0</offset>
      <text>E. miR-10b mimic regulates 5'UTR Luciferase reporters of some splicing factors genes bearing wild type (WT), but not mutated (Mut) miR-10b binding sites. Statistical significance of the differences was determined by Student's t test, with p-values &lt; 0.05 indicated by asterisks, p &lt; 0.01 by two asterisks, and p&lt; 0.001 by three asterisks. Numbers of replicates and exact P-values are included in Appendix Table S4.</text>
      <annotation id="1">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">119</infon>
        <location offset="131" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="2">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">120</infon>
        <location offset="3" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="3">
        <infon key="type">gene:Luciferase</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">412</infon>
        <location offset="33" length="10"/>
        <text>Luciferase</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772951 Figure_5-B</id>
    <infon key="sourcedata_document">1413</infon>
    <infon key="doi">10.15252/emmm.201505495</infon>
    <infon key="pmc_id">4772951</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. 2'-O-MOE-POmiR-10b inhibitor (miR-10b-i) or non-targeting control (1 &#956;g of each) formulated with InVivo-jet PEI were injected intratumorally at days 20 and 25 after cells implantation. The efficacy of miR-10b inhibition was assessed by qRT-PCR analysis of the resected tumors, with miR-10b expression levels normalized to miR-125b.</text>
      <annotation id="1">
        <infon key="type">CHEBI:7754</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">127</infon>
        <location offset="3" length="11"/>
        <text>2'-O-MOE-PO</text>
      </annotation>
      <annotation id="2">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">129</infon>
        <location offset="14" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="3">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">130</infon>
        <location offset="33" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="4">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">131</infon>
        <location offset="205" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="5">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">132</infon>
        <location offset="286" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="6">
        <infon key="type">gene:miR-125b</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">133</infon>
        <location offset="326" length="8"/>
        <text>miR-125b</text>
      </annotation>
      <annotation id="7">
        <infon key="type">Uberon:UBERON:0000479</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">407</infon>
        <location offset="273" length="6"/>
        <text>tumors</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772951 Figure_5-C</id>
    <infon key="sourcedata_document">1413</infon>
    <infon key="doi">10.15252/emmm.201505495</infon>
    <infon key="pmc_id">4772951</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. qRT-PCR analysis demonstrates that miR-10b inhibition in orthotopic GBM8 leads do de-repression of its mRNA targets. mRNA expression levels were normalized to GAPDH.</text>
      <annotation id="1">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">135</infon>
        <location offset="38" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="2">
        <infon key="type">CL:0000047</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">136</infon>
        <location offset="71" length="4"/>
        <text>GBM8</text>
      </annotation>
      <annotation id="3">
        <infon key="type">gene:GAPDH</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">137</infon>
        <location offset="162" length="5"/>
        <text>GAPDH</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772951 Figure_5-D</id>
    <infon key="sourcedata_document">1413</infon>
    <infon key="doi">10.15252/emmm.201505495</infon>
    <infon key="pmc_id">4772951</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. Inverse correlation between miR-10b levels and expression of its mRNA targets in resected GBM8tumors.</text>
      <annotation id="1">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">146</infon>
        <location offset="31" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="2">
        <infon key="type">CL:0000047</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">147</infon>
        <location offset="93" length="4"/>
        <text>GBM8</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772951 Figure_5-E</id>
    <infon key="sourcedata_document">1413</infon>
    <infon key="doi">10.15252/emmm.201505495</infon>
    <infon key="pmc_id">4772951</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>E. Inhibition of miR-10b markedly reduces tumor burden. The left panels illustrate tumor imaging in representative animals at day 29. The bars represent average signal ratios for each group at day 29 (after treatment) to day 20 (at the beginning of treatment). N = 7 animals per group at treatment initiation.</text>
      <annotation id="1">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">161</infon>
        <location offset="17" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="2">
        <infon key="type">Uberon:UBERON:0000479</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">162</infon>
        <location offset="42" length="5"/>
        <text>tumor</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772951 Figure_5-F</id>
    <infon key="sourcedata_document">1413</infon>
    <infon key="doi">10.15252/emmm.201505495</infon>
    <infon key="pmc_id">4772951</infon>
    <infon key="figure">Figure 5-F</infon>
    <infon key="sourcedata_figure_dir">Figure_5-F</infon>
    <passage>
      <offset>0</offset>
      <text>F. Growth curves of individual tumors, based on the ratios of bioluminescence signals to the baseline signals at day 5.</text>
      <annotation id="1">
        <infon key="type">Uberon:UBERON:0000479</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">166</infon>
        <location offset="31" length="6"/>
        <text>tumors</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772951 Figure_5-G</id>
    <infon key="sourcedata_document">1413</infon>
    <infon key="doi">10.15252/emmm.201505495</infon>
    <infon key="pmc_id">4772951</infon>
    <infon key="figure">Figure 5-G</infon>
    <infon key="sourcedata_figure_dir">Figure_5-G</infon>
    <passage>
      <offset>0</offset>
      <text>G. Each mouse was sacrificed when the tumor-generated signal reached 1.5x107 photons/sec, and Kaplan-Meier survival plots were built retrospectively.</text>
      <annotation id="1">
        <infon key="type">NCBI taxon:10090</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">178</infon>
        <location offset="8" length="5"/>
        <text>mouse</text>
      </annotation>
      <annotation id="2">
        <infon key="type">Uberon:UBERON:0000479</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">179</infon>
        <location offset="38" length="5"/>
        <text>tumor</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772951 Figure_6-A</id>
    <infon key="sourcedata_document">1413</infon>
    <infon key="doi">10.15252/emmm.201505495</infon>
    <infon key="pmc_id">4772951</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Intravenously injected Cy5-labeled 2'-O-MOE-PSoligonucleotide is distributed to intracranialGBM8tumor. In the normal brain, the signal is observed in blood vessels but not within brain parenchyma. "T" - tumor, "B" - brain tissue. Each image is representative of three mice analyzed.</text>
      <annotation id="1">
        <infon key="type">molecule:Cy5</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">188</infon>
        <location offset="26" length="3"/>
        <text>Cy5</text>
      </annotation>
      <annotation id="2">
        <infon key="type">CHEBI:7754</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">189</infon>
        <location offset="38" length="11"/>
        <text>2'-O-MOE-PS</text>
      </annotation>
      <annotation id="3">
        <infon key="type">Uberon:UBERON:0013411</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">190</infon>
        <location offset="83" length="12"/>
        <text>intracranial</text>
      </annotation>
      <annotation id="4">
        <infon key="type">Uberon:UBERON:0001981</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">191</infon>
        <location offset="153" length="13"/>
        <text>blood vessels</text>
      </annotation>
      <annotation id="5">
        <infon key="type">Uberon:UBERON:0000353</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">192</infon>
        <location offset="182" length="16"/>
        <text>brain parenchyma</text>
      </annotation>
      <annotation id="6">
        <infon key="type">CHEBI:7754</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">193</infon>
        <location offset="49" length="15"/>
        <text>oligonucleotide</text>
      </annotation>
      <annotation id="7">
        <infon key="type">CL:0000047</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">194</infon>
        <location offset="95" length="4"/>
        <text>GBM8</text>
      </annotation>
      <annotation id="8">
        <infon key="type">Uberon:UBERON:0000479</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">195</infon>
        <location offset="99" length="5"/>
        <text>tumor</text>
      </annotation>
      <annotation id="9">
        <infon key="type">Uberon:UBERON:0000955</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">196</infon>
        <location offset="120" length="5"/>
        <text>brain</text>
      </annotation>
      <annotation id="10">
        <infon key="type">Uberon:UBERON:0000479</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">197</infon>
        <location offset="206" length="5"/>
        <text>tumor</text>
      </annotation>
      <annotation id="11">
        <infon key="type">Uberon:UBERON:0000955</infon>
        <infon key="sourcedata_figure_annot_id">11</infon>
        <infon key="sourcedata_article_annot_id">198</infon>
        <location offset="219" length="5"/>
        <text>brain</text>
      </annotation>
      <annotation id="12">
        <infon key="type">NCBI taxon:10090</infon>
        <infon key="sourcedata_figure_annot_id">12</infon>
        <infon key="sourcedata_article_annot_id">200</infon>
        <location offset="271" length="4"/>
        <text>mice</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772951 Figure_6-B</id>
    <infon key="sourcedata_document">1413</infon>
    <infon key="doi">10.15252/emmm.201505495</infon>
    <infon key="pmc_id">4772951</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>B-D. Systemic inhibition of miR-10b markedly reduces tumor burden. Uncomplexed 2'-O-MOE-PSmiR-10b inhibitor (miR-10b-i) or non-targeting control of the same chemistry were injected at 80 mg/kg through the tail vein at the days indicated by arrows. B. The left panels illustrate tumorimages of representative animals at day 34, and average signals (photons/sec) are indicated below the images. The bars represent average signal ratios for each group at day 34, relative to day 6</text>
      <annotation id="1">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">204</infon>
        <location offset="28" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="2">
        <infon key="type">Uberon:UBERON:0000479</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">205</infon>
        <location offset="53" length="5"/>
        <text>tumor</text>
      </annotation>
      <annotation id="3">
        <infon key="type">CHEBI:7754</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">206</infon>
        <location offset="79" length="11"/>
        <text>2'-O-MOE-PS</text>
      </annotation>
      <annotation id="4">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">207</infon>
        <location offset="90" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="5">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">208</infon>
        <location offset="109" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="6">
        <infon key="type">Uberon:UBERON:0000479</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">209</infon>
        <location offset="278" length="5"/>
        <text>tumor</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772951 Figure_6-C-D</id>
    <infon key="sourcedata_document">1413</infon>
    <infon key="doi">10.15252/emmm.201505495</infon>
    <infon key="pmc_id">4772951</infon>
    <infon key="figure">Figure 6-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>B-D. Systemic inhibition of miR-10b markedly reduces tumor burden. Uncomplexed 2'-O-MOE-PSmiR-10b inhibitor (miR-10b-i) or non-targeting control of the same chemistry were injected at 80 mg/kg through the tail vein at the days indicated by arrows. B. The left panels illustrate tumorimages of representative animals at day 34, and average signals (photons/sec) are indicated below the images. The bars represent average signal ratios for each group at day 34, relative to day 6. C. Each mouse was sacrificed when the tumor-generated signal reached 5X107 photons/sec, and Kaplan-Meier survival plots were built retrospectively. D. Growth curves of individual tumors based on the ratios of bioluminescence signals to the baseline signals at day 6.</text>
      <annotation id="1">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">215</infon>
        <location offset="28" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="2">
        <infon key="type">Uberon:UBERON:0000479</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">216</infon>
        <location offset="53" length="5"/>
        <text>tumor</text>
      </annotation>
      <annotation id="3">
        <infon key="type">CHEBI:7754</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">217</infon>
        <location offset="79" length="11"/>
        <text>2'-O-MOE-PS</text>
      </annotation>
      <annotation id="4">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">218</infon>
        <location offset="90" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="5">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">219</infon>
        <location offset="109" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="6">
        <infon key="type">Uberon:UBERON:0000479</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">220</infon>
        <location offset="278" length="5"/>
        <text>tumor</text>
      </annotation>
      <annotation id="7">
        <infon key="type">NCBI taxon:10090</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">226</infon>
        <location offset="487" length="5"/>
        <text>mouse</text>
      </annotation>
      <annotation id="8">
        <infon key="type">Uberon:UBERON:0000479</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">227</infon>
        <location offset="517" length="5"/>
        <text>tumor</text>
      </annotation>
      <annotation id="9">
        <infon key="type">Uberon:UBERON:0000479</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">230</infon>
        <location offset="658" length="6"/>
        <text>tumors</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772951 Figure_6-E</id>
    <infon key="sourcedata_document">1413</infon>
    <infon key="doi">10.15252/emmm.201505495</infon>
    <infon key="pmc_id">4772951</infon>
    <infon key="figure">Figure 6-E</infon>
    <infon key="sourcedata_figure_dir">Figure_6-E</infon>
    <passage>
      <offset>0</offset>
      <text>E. The efficacy of miR-10b inhibition in intracranialtumors was assessed by qRT-PCR analysis of the resected tumor tissues, with miR-10b expression levels normalized to miR-125b.</text>
      <annotation id="1">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">235</infon>
        <location offset="19" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="2">
        <infon key="type">Uberon:UBERON:0013411</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">236</infon>
        <location offset="41" length="12"/>
        <text>intracranial</text>
      </annotation>
      <annotation id="3">
        <infon key="type">Uberon:UBERON:0000479</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">237</infon>
        <location offset="53" length="6"/>
        <text>tumors</text>
      </annotation>
      <annotation id="4">
        <infon key="type">Uberon:UBERON:0000479</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">238</infon>
        <location offset="109" length="5"/>
        <text>tumor</text>
      </annotation>
      <annotation id="5">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">239</infon>
        <location offset="129" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="6">
        <infon key="type">gene:miR-125b</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">240</infon>
        <location offset="169" length="8"/>
        <text>miR-125b</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772951 Figure_6-F</id>
    <infon key="sourcedata_document">1413</infon>
    <infon key="doi">10.15252/emmm.201505495</infon>
    <infon key="pmc_id">4772951</infon>
    <infon key="figure">Figure 6-F</infon>
    <infon key="sourcedata_figure_dir">Figure_6-F</infon>
    <passage>
      <offset>0</offset>
      <text>F. qRT-PCR analysis demonstrates that miR-10b targets were de-repressed in orthotopic GBM8 upon systemic administration of the miR-10b inhibitor. Seven tumors per condition, and two specimens per tumor have been analyzed. mRNA expression levels were normalized to GAPDH.</text>
      <annotation id="1">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">242</infon>
        <location offset="38" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="2">
        <infon key="type">CL:0000047</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">243</infon>
        <location offset="86" length="4"/>
        <text>GBM8</text>
      </annotation>
      <annotation id="3">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">244</infon>
        <location offset="127" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="4">
        <infon key="type">Uberon:UBERON:0000479</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">245</infon>
        <location offset="152" length="6"/>
        <text>tumors</text>
      </annotation>
      <annotation id="5">
        <infon key="type">Uberon:UBERON:0000479</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">246</infon>
        <location offset="196" length="5"/>
        <text>tumor</text>
      </annotation>
      <annotation id="6">
        <infon key="type">gene:GAPDH</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">247</infon>
        <location offset="264" length="5"/>
        <text>GAPDH</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772951 Figure_6-G</id>
    <infon key="sourcedata_document">1413</infon>
    <infon key="doi">10.15252/emmm.201505495</infon>
    <infon key="pmc_id">4772951</infon>
    <infon key="figure">Figure 6-G</infon>
    <infon key="sourcedata_figure_dir">Figure_6-G</infon>
    <passage>
      <offset>0</offset>
      <text>G. Inverse correlation between miR-10b levels and expression of its mRNA targets in resected GBM8tumors.</text>
      <annotation id="1">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">256</infon>
        <location offset="31" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="2">
        <infon key="type">CL:0000047</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">257</infon>
        <location offset="93" length="4"/>
        <text>GBM8</text>
      </annotation>
      <annotation id="3">
        <infon key="type">Uberon:UBERON:0000479</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">258</infon>
        <location offset="97" length="6"/>
        <text>tumors</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772951 Figure_7-A</id>
    <infon key="sourcedata_document">1413</infon>
    <infon key="doi">10.15252/emmm.201505495</infon>
    <infon key="pmc_id">4772951</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Uptake of the uncomplexed Cy5-labeled 2'-O-MOE-PSoligonucleotide (80 mg/kg injected via the tail vein) by normal extracranial tissues was examined by fluorescence microscopy24 h after injections.</text>
      <annotation id="1">
        <infon key="type">molecule:Cy5</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">275</infon>
        <location offset="29" length="3"/>
        <text>Cy5</text>
      </annotation>
      <annotation id="2">
        <infon key="type">CHEBI:7754</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">276</infon>
        <location offset="41" length="11"/>
        <text>2'-O-MOE-PS</text>
      </annotation>
      <annotation id="3">
        <infon key="type">CHEBI:7754</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">277</infon>
        <location offset="52" length="15"/>
        <text>oligonucleotide</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772951 Figure_7-B-C-D</id>
    <infon key="sourcedata_document">1413</infon>
    <infon key="doi">10.15252/emmm.201505495</infon>
    <infon key="pmc_id">4772951</infon>
    <infon key="figure">Figure 7-B-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>B-D. Systemic treatment of intracranialGBM8tumors with uncomplexed 2'-O-MOE-PSmiR-10b inhibitor (miR-10b-i) or non-targeting control oligonucleotide (at 80 mg/kg) was not associated with toxic effects. B. No significant difference in average mice weight was observed between the anti-miR-10b and control treatment groups. C. No significant difference in average organs' weight was observed between the anti-miR-10b and control treatment groups. D. No significant difference in tissue histology using Hematoxylin and Eosin staining was observed between the anti-miR-10b and control treatment groups.</text>
      <annotation id="1">
        <infon key="type">Uberon:UBERON:0013411</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">284</infon>
        <location offset="27" length="12"/>
        <text>intracranial</text>
      </annotation>
      <annotation id="2">
        <infon key="type">CL:0000047</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">285</infon>
        <location offset="39" length="4"/>
        <text>GBM8</text>
      </annotation>
      <annotation id="3">
        <infon key="type">Uberon:UBERON:0000479</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">286</infon>
        <location offset="43" length="6"/>
        <text>tumors</text>
      </annotation>
      <annotation id="4">
        <infon key="type">CHEBI:7754</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">287</infon>
        <location offset="67" length="11"/>
        <text>2'-O-MOE-PS</text>
      </annotation>
      <annotation id="5">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">288</infon>
        <location offset="78" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="6">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">289</infon>
        <location offset="97" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="7">
        <infon key="type">CHEBI:7754</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">290</infon>
        <location offset="133" length="15"/>
        <text>oligonucleotide</text>
      </annotation>
      <annotation id="8">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">291</infon>
        <location offset="284" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="9">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">292</infon>
        <location offset="407" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="10">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">293</infon>
        <location offset="561" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="11">
        <infon key="type">NCBI taxon:10090</infon>
        <infon key="sourcedata_figure_annot_id">11</infon>
        <infon key="sourcedata_article_annot_id">294</infon>
        <location offset="242" length="4"/>
        <text>mice</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772951 Figure_8-A</id>
    <infon key="sourcedata_document">1413</infon>
    <infon key="doi">10.15252/emmm.201505495</infon>
    <infon key="pmc_id">4772951</infon>
    <infon key="figure">Figure 8-A</infon>
    <infon key="sourcedata_figure_dir">Figure_8-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Continuous osmotic delivery of miR-10b inhibitor markedly reduces tumor burden. The osmotic pumps, loaded with lipid nanoparticles formulated with 2'-O-MOE-POmiR-10b inhibitor or non-targeting control infused 2 &#956;g of the oligonucleotides per day introtumorally, over 13 days. Tumors growth was monitored by the WBI, and the left panels illustrate tumor imaging of representative animals at the end of treatment. The bars represent average signal ratios for each group at day 13 (end of treatment), relative to day 2 (treatment initiation).</text>
      <annotation id="1">
        <infon key="type">CHEBI:50803|CHEBI:18059</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">301</infon>
        <location offset="114" length="19"/>
        <text>lipid nanoparticles</text>
      </annotation>
      <annotation id="2">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">306</infon>
        <location offset="34" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="3">
        <infon key="type">Uberon:UBERON:0000479</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">307</infon>
        <location offset="69" length="5"/>
        <text>tumor</text>
      </annotation>
      <annotation id="4">
        <infon key="type">CHEBI:7754</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">308</infon>
        <location offset="150" length="11"/>
        <text>2'-O-MOE-PO</text>
      </annotation>
      <annotation id="5">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">309</infon>
        <location offset="161" length="7"/>
        <text>miR-10b</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772951 Figure_8-B</id>
    <infon key="sourcedata_document">1413</infon>
    <infon key="doi">10.15252/emmm.201505495</infon>
    <infon key="pmc_id">4772951</infon>
    <infon key="figure">Figure 8-B</infon>
    <infon key="sourcedata_figure_dir">Figure_8-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Representative immunostaining of tumors for PCNAproliferation marker.</text>
      <annotation id="1">
        <infon key="type">Uberon:UBERON:0000479</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">314</infon>
        <location offset="36" length="6"/>
        <text>tumors</text>
      </annotation>
      <annotation id="2">
        <infon key="type">Uniprot:P17918</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">315</infon>
        <location offset="47" length="4"/>
        <text>PCNA</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772951 Figure_8-C</id>
    <infon key="sourcedata_document">1413</infon>
    <infon key="doi">10.15252/emmm.201505495</infon>
    <infon key="pmc_id">4772951</infon>
    <infon key="figure">Figure 8-C</infon>
    <infon key="sourcedata_figure_dir">Figure_8-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. Representative immunostaining of the tumors for KI67 proliferation marker.</text>
      <annotation id="1">
        <infon key="type">Uniprot:Q91VE6</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">319</infon>
        <location offset="51" length="4"/>
        <text>KI67</text>
      </annotation>
      <annotation id="2">
        <infon key="type">Uberon:UBERON:0000479</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">321</infon>
        <location offset="40" length="6"/>
        <text>tumors</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772951 Figure_8-D</id>
    <infon key="sourcedata_document">1413</infon>
    <infon key="doi">10.15252/emmm.201505495</infon>
    <infon key="pmc_id">4772951</infon>
    <infon key="figure">Figure 8-D</infon>
    <infon key="sourcedata_figure_dir">Figure_8-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. Representative tumorimmunostaining for cleaved Caspase 3 as a marker of apoptosis.</text>
      <annotation id="1">
        <infon key="type">Uniprot:P70677</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">325</infon>
        <location offset="50" length="9"/>
        <text>Caspase 3</text>
      </annotation>
      <annotation id="2">
        <infon key="type">Uberon:UBERON:0000479</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">326</infon>
        <location offset="18" length="5"/>
        <text>tumor</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772951 Figure_8-E</id>
    <infon key="sourcedata_document">1413</infon>
    <infon key="doi">10.15252/emmm.201505495</infon>
    <infon key="pmc_id">4772951</infon>
    <infon key="figure">Figure 8-E</infon>
    <infon key="sourcedata_figure_dir">Figure_8-E</infon>
    <passage>
      <offset>0</offset>
      <text>E. Tumorcell invasion was examined by fluorescence microscopy for mCherry-positive cells migrating through the tumor border.</text>
      <annotation id="1">
        <infon key="type">Uberon:UBERON:0000479</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">331</infon>
        <location offset="3" length="5"/>
        <text>Tumor</text>
      </annotation>
      <annotation id="2">
        <infon key="type">protein:mCherry</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">332</infon>
        <location offset="66" length="7"/>
        <text>mCherry</text>
      </annotation>
      <annotation id="3">
        <infon key="type">Uberon:UBERON:0000479</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">333</infon>
        <location offset="111" length="5"/>
        <text>tumor</text>
      </annotation>
      <annotation id="4">
        <infon key="type">CL:0000000</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">335</infon>
        <location offset="8" length="4"/>
        <text>cell</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772951 Figure_8-F</id>
    <infon key="sourcedata_document">1413</infon>
    <infon key="doi">10.15252/emmm.201505495</infon>
    <infon key="pmc_id">4772951</infon>
    <infon key="figure">Figure 8-F</infon>
    <infon key="sourcedata_figure_dir">Figure_8-F</infon>
    <passage>
      <offset>0</offset>
      <text>F. Quantitative immunostainings analysis indicates that proliferation and apoptosis markers are affected by anti-miR-10b treatment. No significant effect on invasion of intracranialGBM8 was observed.</text>
      <annotation id="1">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">338</infon>
        <location offset="113" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="2">
        <infon key="type">Uberon:UBERON:0013411</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">339</infon>
        <location offset="169" length="12"/>
        <text>intracranial</text>
      </annotation>
      <annotation id="3">
        <infon key="type">CL:0000047</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">340</infon>
        <location offset="181" length="4"/>
        <text>GBM8</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772951 Figure_9-A-B</id>
    <infon key="sourcedata_document">1413</infon>
    <infon key="doi">10.15252/emmm.201505495</infon>
    <infon key="pmc_id">4772951</infon>
    <infon key="figure">Figure 9-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_9-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A, B. miR-10b inhibition decreases GL261 cellviability. Cellviability was measured at days 3-7 after transfection with miR-10b inhibitor, non-targeting control, or Lipofectamine 2000 alone (mock). A. Phase contrast photographs of GL261 cultures at day 6 post-transfection. B. Growth curves of cultured GL261 cells, based on the viability assay.</text>
      <annotation id="1">
        <infon key="type">CVCL_Y003</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">344</infon>
        <location offset="35" length="5"/>
        <text>GL261</text>
      </annotation>
      <annotation id="2">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">347</infon>
        <location offset="6" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="3">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">352</infon>
        <location offset="119" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="4">
        <infon key="type">molecule:Lipofectamine 2000</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">353</infon>
        <location offset="164" length="18"/>
        <text>Lipofectamine 2000</text>
      </annotation>
      <annotation id="5">
        <infon key="type">CVCL_Y003</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">355</infon>
        <location offset="230" length="5"/>
        <text>GL261</text>
      </annotation>
      <annotation id="6">
        <infon key="type">CVCL_Y003</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">358</infon>
        <location offset="302" length="5"/>
        <text>GL261</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772951 Figure_9-C</id>
    <infon key="sourcedata_document">1413</infon>
    <infon key="doi">10.15252/emmm.201505495</infon>
    <infon key="pmc_id">4772951</infon>
    <infon key="figure">Figure 9-C</infon>
    <infon key="sourcedata_figure_dir">Figure_9-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. InVivo-jet PEI - formulated 2'-O-MOE-PS/POmiR-10b inhibitor or non-targeting control were infused to orthotopic GL261tumors by osmotic pumps, starting at day 6 after cell implantation. The uptake of ASOs was confirmed by IHC for PS-containing oligonucleotides (green). GL261tumor cells expressing M-Cherry are red.</text>
      <annotation id="1">
        <infon key="type">PubChem:167253</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">362</infon>
        <location offset="232" length="2"/>
        <text>PS</text>
      </annotation>
      <annotation id="2">
        <infon key="type">protein:M-Cherry</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">363</infon>
        <location offset="300" length="8"/>
        <text>M-Cherry</text>
      </annotation>
      <annotation id="3">
        <infon key="type">CHEBI:7754</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">364</infon>
        <location offset="31" length="11"/>
        <text>2'-O-MOE-PS</text>
      </annotation>
      <annotation id="4">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">366</infon>
        <location offset="45" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="5">
        <infon key="type">CVCL_Y003</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">367</infon>
        <location offset="115" length="5"/>
        <text>GL261</text>
      </annotation>
      <annotation id="6">
        <infon key="type">Uberon:UBERON:0000479</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">368</infon>
        <location offset="120" length="6"/>
        <text>tumors</text>
      </annotation>
      <annotation id="7">
        <infon key="type">CVCL_Y003</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">371</infon>
        <location offset="272" length="5"/>
        <text>GL261</text>
      </annotation>
      <annotation id="8">
        <infon key="type">Uberon:UBERON:0000479</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">372</infon>
        <location offset="277" length="5"/>
        <text>tumor</text>
      </annotation>
      <annotation id="9">
        <infon key="type">PubChem:16133915</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">373</infon>
        <location offset="43" length="2"/>
        <text>PO</text>
      </annotation>
      <annotation id="10">
        <infon key="type">CHEBI:76720</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">374</infon>
        <location offset="202" length="3"/>
        <text>ASO</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772951 Figure_9-D</id>
    <infon key="sourcedata_document">1413</infon>
    <infon key="doi">10.15252/emmm.201505495</infon>
    <infon key="pmc_id">4772951</infon>
    <infon key="figure">Figure 9-D</infon>
    <infon key="sourcedata_figure_dir">Figure_9-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. Osmotic delivery of miR-10b inhibitor markedly reduces GL261tumorgrowth in immunocompetent Black 6 Albino mice. Micephotographs show tumor imaging in representative animals at day 3 after pump implantation, and average signals in photons per second are indicated. Tumorgrowth rates were calculated as ratios of the signals at day 3 of the treatment to day 1 prior to initiation of the treatment.</text>
      <annotation id="1">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">376</infon>
        <location offset="23" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="2">
        <infon key="type">CVCL_Y003</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">377</infon>
        <location offset="58" length="5"/>
        <text>GL261</text>
      </annotation>
      <annotation id="3">
        <infon key="type">Uberon:UBERON:0000479</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">378</infon>
        <location offset="63" length="5"/>
        <text>tumor</text>
      </annotation>
      <annotation id="4">
        <infon key="type">NCBI taxon:10090</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">380</infon>
        <location offset="109" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="5">
        <infon key="type">NCBI taxon:10090</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">381</infon>
        <location offset="115" length="4"/>
        <text>Mice</text>
      </annotation>
      <annotation id="6">
        <infon key="type">Uberon:UBERON:0000479</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">383</infon>
        <location offset="136" length="5"/>
        <text>tumor</text>
      </annotation>
      <annotation id="7">
        <infon key="type">Uberon:UBERON:0000479</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">385</infon>
        <location offset="267" length="5"/>
        <text>Tumor</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772951 Figure_9-E</id>
    <infon key="sourcedata_document">1413</infon>
    <infon key="doi">10.15252/emmm.201505495</infon>
    <infon key="pmc_id">4772951</infon>
    <infon key="figure">Figure 9-E</infon>
    <infon key="sourcedata_figure_dir">Figure_9-E</infon>
    <passage>
      <offset>0</offset>
      <text>E. The efficacy of miR-10b inhibition in intracranialtumors was assessed by qRT-PCR analysis of the resected tumor tissues, with miR-10b expression levels normalized to miR-125b.</text>
      <annotation id="1">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">392</infon>
        <location offset="19" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="2">
        <infon key="type">Uberon:UBERON:0013411</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">393</infon>
        <location offset="41" length="12"/>
        <text>intracranial</text>
      </annotation>
      <annotation id="3">
        <infon key="type">Uberon:UBERON:0000479</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">394</infon>
        <location offset="53" length="6"/>
        <text>tumors</text>
      </annotation>
      <annotation id="4">
        <infon key="type">Uberon:UBERON:0000479</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">395</infon>
        <location offset="109" length="5"/>
        <text>tumor</text>
      </annotation>
      <annotation id="5">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">396</infon>
        <location offset="129" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="6">
        <infon key="type">gene:miR-125b</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">397</infon>
        <location offset="169" length="8"/>
        <text>miR-125b</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772951 Figure_9-F</id>
    <infon key="sourcedata_document">1413</infon>
    <infon key="doi">10.15252/emmm.201505495</infon>
    <infon key="pmc_id">4772951</infon>
    <infon key="figure">Figure 9-F</infon>
    <infon key="sourcedata_figure_dir">Figure_9-F</infon>
    <passage>
      <offset>0</offset>
      <text>F. qRT-PCR analysis demonstrates that miR-10b target p21 was de-repressed in GL261tumors upon miR-10b inhibition. mRNA expression levels were normalized to GAPDH.</text>
      <annotation id="1">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">400</infon>
        <location offset="38" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="2">
        <infon key="type">NCBI gene:12575</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">401</infon>
        <location offset="53" length="3"/>
        <text>p21</text>
      </annotation>
      <annotation id="3">
        <infon key="type">CVCL_Y003</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">402</infon>
        <location offset="77" length="5"/>
        <text>GL261</text>
      </annotation>
      <annotation id="4">
        <infon key="type">Uberon:UBERON:0000479</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">403</infon>
        <location offset="82" length="6"/>
        <text>tumors</text>
      </annotation>
      <annotation id="5">
        <infon key="type">NCBI gene:406903</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">404</infon>
        <location offset="94" length="7"/>
        <text>miR-10b</text>
      </annotation>
      <annotation id="6">
        <infon key="type">gene:GAPDH</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">406</infon>
        <location offset="156" length="5"/>
        <text>GAPDH</text>
      </annotation>
    </passage>
  </document>
</collection>
